"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 11

E-magazine
  • Previous Issues

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
26 May 2011

Company Profile: KGK Synergize Inc.

KGK Synergize, Inc. | www.kgksynergize.com

No Comments

Established in June 1997 as a research and development company, KGK Synergize was founded by three scientists associated for many years with The Centre for Human Nutrition located at The University of Western Ontario. The company was initially created to facilitate commercialization of their Research and Development findings.

KGK Synergize Inc. is comprised of two divisions.

Contract Research Services offers a wide range of research services to identify various health benefits from preclinical to clinical trials, data analysis and consultation. Focused on biotechnology, pharmaceutical and nutraceutical research, the contract research division boasts a global reputation for uncompromising science as well as a number of "repeat client" relationships with well-known multi-national firms.

The Product Development division implements screening techniques to develop nutraceutical and functional food products to the point where they are ready to market. Already a registered holder of three US patents - with another 8 pending - our product development success to date has been nothing short of extraordinary.

Regardless of the endeavor, clients have come to trust the scientific excellence, unparalleled service and reputation for quality results that have made KGK Synergize a leader in the North American industry.


More like this...

  • Survive and Thrive

    Four years ago it looked like Schering-Plough might not survive the patent loss of Claritin. Twelve consecutive quarters of adjusted sales growth and substantial R&D...
    Read more
  • New Business Value

    Giles Day, Senior Director of the Targets and Mechanisms Informatics Group, Pfizer explains the three areas that he is focusing on to become more...

    Read more
  • Translational Research and Biomarkers

    Dominic Spinella, Head of Translational Medicine for Pfizer Oncology, explains the concept and how this new research will help pharma move forward.
    Read more
  • Prioritization of Vaccines

    At the September 2007 NGP Discovery & Development Summit in Arizona,Anthony Ford-Hutchinson led a fascinating workshop on the prioritization of...

    Read more
  • Ambition and More

    Dr. Thomas Chan, SVP of Discovery and Development at ArQule gives NGP his insight into what a small biotechnology company are concentrating on in the...

    Read more
  • Moving Clinical Trials Forward

    Dr. Richard Polisson is one busy man. As well as being the Senior Vice President of Clinical Research for Genzyme, overseeing the design and implementation of clinical...

    Read more
Disclaimer: All comments posted in a personal capacity
POST A COMMENT
In order to post a comment you need to be regsitered and signed in.
Register | Sign in
No Comments Have Been Submitted
Disclaimer: All comments posted in a personal capacity